表紙
市場調査レポート

世界の受託医薬品製造・研究・パッケージング市場 - 受託製造市場

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging - Focus on Contract Manufacturing

発行 BCC Research 商品コード 278826
出版日 ページ情報 英文 189 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
世界の受託医薬品製造・研究・パッケージング市場 - 受託製造市場 Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging - Focus on Contract Manufacturing
出版日: 2013年08月19日 ページ情報: 英文 189 Pages
概要

当レポートでは、世界の受託医薬品製造・研究・パッケージング市場概要について、市場の現況と展望および全体的な医薬品・アウトソーシング産業の包括的分析に重点を置いて示しており、実績データ・推計・CAGR予測を含めた世界市場の動向分析、市場セグメント別の分析、市場のアウトソーシングニーズ、規制環境、最新動向と発展を含めた技術課題、特許分析および主要企業のプロファイルなどを提供しており、概略下記の構成でお届けいたします。

第1章 イントロダクション

第2章 サマリー

第3章 概要

  • 定義
  • アウトソーシングの理由
  • アウトソーシングの歴史
  • 受託製造
  • 受託研究

第4章 規制状況

  • 行政警告書
  • 規制認可

第5章 新規開発

  • LONZA
  • BRISTOL-MYERS SQUIBB
  • ABBOTT
  • ALBANY MOLECULAR RESEARCH INC. (AMRI)
  • EVOTEC AG
  • HOSPIRA
  • COVIDIEN
  • DR. REDDY'S LABORATORIES
  • その他

第6章 世界の受託製造・研究・パッケージング市場

  • 市場:タイプ別
  • 市場:地域別

第7章 受託製造市場

  • バルク薬剤/医薬品活性成分の受託製造
  • 剤形の受託製造

第8章 受託研究市場

  • 市場:領域別

第9章 受託パッケージング市場

  • 市場:タイプ別
  • 市場:地域別
  • 産業構造

第10章 特許分析

  • 年度別
  • 注目度別
  • 企業別
  • 特許保有国別
  • 特許保有者タイプ別

第11章 現在の市場環境

  • アウトソーシング市場の影響因子

第12章 企業プロファイル

第13章 付録:用語

図表リスト

目次
Product Code: PHM155A

This report provides:

  • An overview of the global market for contract pharmaceutical manufacturing, research, and packaging, with emphasis on the current and future outlook of the market and a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry.
  • Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Examination of the effects on market growth of state-of-the-art packaging facilities as well as expensive research facilities and the capabilities of research organizations.
  • Coverage of the market's need for outsourcing, the regulatory environment, and technological issues, including the latest trends and developments.
  • Comprehensive company profiles of major players.

SAMPLE FIGURE
GLOBAL MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL
CONTRACT MANUFACTURING, RESEARCH AND PACKAGING,
2011-2018 ($ BILLIONS)

Source: BCC Research

STUDY OBJECTIVE

BCC Research's objective in conducting this study is to provide an overview of the current and future global pharmaceutical contract manufacturing, research and packaging markets. The study provides a global as well as a regionally specific market overview. The key objective is to present a comprehensive analysis of the current and future direction of contract manufacturing, research and packaging as an important tool for a company's growth and financial stability and as a way to overcome various trade barriers. It also addresses the role of these organizations in reducing costs, meeting strict regulatory requirements globally, dealing with the effects of patent expiries on market share and in competing in a highly competitive and tough business environment.

A detailed analysis of the industry structure of contract manufacturing, contract research and contract packaging has been conducted. Revenues are broken down by type of industry. Sales figures are estimated for the five-year period from 2013 through 2018.

Applications and various formulations for which contract manufacturing, research and packaging are widely used are also discussed separately in the report. The report also takes into account various new developments and regulatory aspects in this industry. The report also covers significant patents in each category.

REASONS FOR DOING THIS STUDY

Comprehensive research in the fields of contract manufacturing, contract research and contract packaging has revealed their benefits in various industries. Contract manufacturing, research and packaging are advantageous to both parties to the contract as it provides the manufacturing company with financial stability for the duration of the contract and the hiring company the benefit of cost savings, time saved in operating and managing a production facility and research. Many industries have now begun to explore the advantages of contracting their research, production and packaging, leading to a steady market for these services.

Cost control, R&D spend, new technologies, increasing competition and patent expiries resulting in markets for generics are moving this industry in a new direction. New advancements, product launches and changing technologies will drive the growth of the market in the foreseeable future. This study looks at most of the systems affected by these factors.

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type of technology in light of the new technologies, growing competition and changing market needs.

SCOPE OF THE STUDY

The scope of this study encompasses contract manufacturers, contract research and contract packaging in the pharmaceutical and biotechnology markets. BCC analyzes each market and its applications, regulatory environment, technology, market projections and market shares. Technological issues include the latest trends and developments. The emerging markets for contract manufacturing research and packaging include countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

INFORMATION SOURCES

Many companies were surveyed to obtain data for this study. Included were manufacturers and end users of kinase inhibitors in various therapeutic categories and disease segments. Data were gathered from various industry sources. BCC spoke with officials within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

ABOUT THE AUTHOR

A team of professionals in the biotechnology industry carried out this study. The project manager is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has more than 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest such as ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and the U.S.

The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in the life sciences. She has a number of research publications to her credit, including her thesis, which was given an award of excellence.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ABOUT THE AUTHOR
  • RELATED BCC RESEARCH REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL CONTRACT MANUFACTURING, RESEARCH AND PACKAGING, THROUGH 2018 ($ BILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL CONTRACT MANUFACTURING, RESEARCH AND PACKAGING, 2011-2018 ($ BILLIONS)

CHAPTER 3 - OVERVIEW

  • DEFINITIONS
    • OUTSOURCING
    • CONTRACT MANUFACTURING
    • CONTRACT MANUFACTURER
    • CORE COMPETENCIES
    • VENDOR
    • CONTRACT RESEARCH ORGANIZATION (CRO)
  • REASONS FOR OUTSOURCING
    • REDUCE AND CONTROL OPERATING COSTS
    • IMPROVE FOCUS ON CORE COMPETENCIES
    • GAIN ACCESS TO WORLD-CLASS CAPABILITIES
    • SHARE RISKS WITH A PARTNER COMPANY
  • HISTORY OF OUTSOURCING
    • TABLE 1: KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
  • CONTRACT MANUFACTURING
    • TYPES OF CONTRACT MANUFACTURERS
      • Supply Manufacturers
      • Toll Manufacturers
        • Types of Toll Manufacturers
          • Vendors of Excess Capacity
          • Providers of Niche Services
          • Academic Institutions
    • SPECIFIC REASONS FOR OUTSOURCING
    • STRATEGIES FOR SUCCESSFUL OUTSOURCING
    • ADVANTAGES AND DISADVANTAGES OF CONTRACT MANUFACTURING
      • TABLE 2: KEY ADVANTAGES OF CONTRACT MANUFACTURING
      • TABLE 3: KEY DISADVANTAGES OF CONTRACT MANUFACTURING
    • SELECTING A CONTRACT MANUFACTURER
      • TABLE 4: KEY FACTORS IN SELECTING A CONTRACT MANUFACTURER
    • IMPORTANT FACTORS IN WORKING WITH A CONTRACT MANUFACTURER
      • Product Quality
      • Cost Competitiveness
      • Delivery Schedule
      • Client-CMO Relationship
  • CONTRACT RESEARCH
    • RESPONSIBILITIES OF CONTRACT RESEARCH ORGANIZATIONS
    • CRO-SPONSOR RELATIONSHIP: KEY TO SUCCESS
    • SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATIONS
      • TABLE 5: SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATIONS
    • SELECTION CRITERIA
      • TABLE 6: KEY FACTORS IN SELECTING A CONTRACT RESEARCH ORGANIZATION
    • RESEARCH PROVIDED BY CONTRACT RESEARCH ORGANIZATIONS
      • TABLE 7: TYPES OF SERVICES PROVIDED BY CONTRACT RESEARCH ORGANIZATIONS
    • CONTRACT PACKAGING
      • NEED FOR CONTRACT PACKAGERS
        • TABLE 8: REASONS COMPANIES HIRE CONTRACT PACKAGERS
      • ETHICAL STANDARDS FOR CONTRACT PACKAGERS

CHAPTER 4 - REGULATORY ASPECTS

  • WARNING LETTERS
    • TABLE 9: WARNING LETTERS ISSUED TO PHARMACEUTICAL CONTRACT MANUFACTURERS, 2012
    • TABLE 10: WARNING LETTERS ISSUED TO PHARMACEUTICAL CONTRACT MANUFACTURERS, 2011
    • TABLE 11: WARNING LETTERS ISSUED TO PHARMACEUTICAL CONTRACT MANUFACTURERS, 2010
  • REGULATORY APPROVALS
    • TABLE 12: REGULATORY APPROVALS OF PHARMACEUTICAL CONTRACT MANUFACTURER ACTIVITIES AND FACILITIES, JAN. AND FEB. 2013
    • TABLE 13: REGULATORY APPROVALS OF PHARMACEUTICAL CONTRACT MANUFACTURER ACTIVITIES AND FACILITIES, 2012
    • TABLE 14: REGULATORY APPROVALS OF PHARMACEUTICAL CONTRACT MANUFACTURER ACTIVITIES AND FACILITIES, 2011
    • TABLE 15: REGULATORY APPROVALS OF CONTRACT MANUFACTURER ACTIVITIES AND FACILITIES, 2010

CHAPTER 5 - NEW DEVELOPMENTS

  • LONZA
  • BRISTOL-MYERS SQUIBB
  • ABBOTT
  • ALBANY MOLECULAR RESEARCH INC. (AMRI)
  • EVOTEC AG
  • HOSPIRA
  • COVIDIEN
  • DR. REDDY'S LABORATORIES
  • OTHER

CHAPTER 6 - GLOBAL MARKETS FOR CONTRACT MANUFACTURING, RESEARCH AND PACKAGING

  • MARKETS BY TYPE
    • CONTRACT MANUFACTURE OF VARIOUS DOSAGE FORMS AND BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS
      • Market Overview
      • Market Revenue
        • TABLE 16: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS AND VARIOUS DOSAGE FORMS, THROUGH 2018 ($ BILLIONS)
        • FIGURE 1: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS AND VARIOUS DOSAGE FORMS, 2011-2018 ($ BILLIONS)
      • Market Shares
        • TABLE 17: MARKET SHARES OF CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS AND VARIOUS DOSAGE FORMS, 2012 (%)
        • FIGURE 2: MARKET SHARES OF CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS AND VARIOUS DOSAGE FORMS, 2012 (%)
    • MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONALS
      • Market Overview
      • Market Revenues
        • TABLE 18: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, THROUGH 2018 ($ BILLIONS)
        • FIGURE 3: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2011-2018 ($ BILLIONS)
      • Market Share
        • TABLE 19: MARKET SHARES OF CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2012 (%)
        • FIGURE 4: MARKET SHARES OF CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2012 (%)
    • MARKET FOR VARIOUS DOSAGE FORMS, BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS AND OTC DRUGS/NUTRITIONALS
      • Market Revenue
        • TABLE 20: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, VARIOUS DOSAGE FORMS AND OTC DRUGS/NUTRITIONAL PRODUCTS, THROUGH 2018 ($ BILLIONS)
        • FIGURE 5: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, VARIOUS DOSAGE FORMS AND OTC DRUGS/NUTRITIONAL PRODUCTS, 2011-2018 ($ BILLIONS)
      • Market Share
        • TABLE 21: MARKET SHARES OF CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, VARIOUS DOSAGE FORMS AND OTC DRUGS/NUTRITIONAL PRODUCTS, 2012 (%)
        • FIGURE 6: MARKET SHARES OF CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, VARIOUS DOSAGE FORMS AND OTC DRUGS/NUTRITIONAL PRODUCTS, 2012 (%)
    • CONTRACT RESEARCH MARKET
      • Market Overview
      • Market Revenue
        • TABLE 22: GLOBAL MARKET FOR CONTRACT RESEARCH BY SEGMENT, THROUGH 2018 ($ BILLIONS)
        • FIGURE 7: GLOBAL MARKET FOR CONTRACT RESEARCH BY SEGMENT, 2011-2018 ($ BILLIONS)
      • Market Shares
        • TABLE 23: CONTRACT RESEARCH MARKET SHARES BY SEGMENT, 2012 (%)
        • FIGURE 8: CONTRACT RESEARCH MARKET SHARES BY SEGMENT, 2012 (%)
    • CONTRACT PACKAGING MARKET
      • Market Overview
      • Market Revenue
        • TABLE 24: GLOBAL MARKET FOR CONTRACT PACKAGING BY TYPE, THROUGH 2018 ($ BILLIONS)
        • FIGURE 9 GLOBAL MARKET FOR CONTRACT PACKAGING BY TYPE, 2011-2018 ($ BILLIONS)
      • Market Share
        • TABLE 25: MARKET SHARES OF CONTRACT PACKAGING BY TYPE, 2012 (%)
        • FIGURE 10: MARKET SHARES OF CONTRACT PACKAGING BY TYPE, 2012 (%)
  • MARKET BY REGION
    • MARKET FOR CONTRACT MANUFACTURE OF VARIOUS DOSAGE FORMS, BULK DRUGS AND ACTIVE PHARMACEUTICAL INGREDIENTS
      • Market Overview
      • Market Revenue
        • TABLE 26: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS AND BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS BY REGION, THROUGH 2018 ($ BILLIONS)
        • FIGURE 11: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS AND BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS BY REGION, 2011-2018 ($ BILLIONS)
      • Market Share
        • TABLE 27 REGIONAL MARKETS SHARES OF CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS AND BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, 2012 (%)
        • FIGURE 12: REGIONAL MARKETS SHARES OF CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS AND BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, 2012 (%)
    • MARKET FOR CONTRACT MANUFACTURING, RESEARCH AND PACKAGING
      • Market Overview
      • Market Revenue
        • TABLE 28: GLOBAL MARKET FOR CONTRACT MANUFACTURING, RESEARCH AND PACKAGING BY REGION, THROUGH 2018 ($ BILLIONS)
        • FIGURE 13: GLOBAL MARKET FOR CONTRACT MANUFACTURING, RESEARCH AND PACKAGING BY REGION, 2011-2018 ($ BILLIONS)
      • Market Share
        • TABLE 29: REGIONAL MARKET SHARES OF CONTRACT MANUFACTURING, RESEARCH AND PACKAGING, 2012 (%)
        • FIGURE 14: REGIONAL MARKET SHARES OF CONTRACT MANUFACTURING, RESEARCH AND PACKAGING, 2012 (%)
    • MARKET BY THERAPEUTIC USE
      • CARDIOVASCULAR DRUGS
      • ONCOLOGY
      • ANTIBIOTICS
      • ANALGESICS
      • ANTIVIRALS
      • REPRODUCTIVE DRUG PRODUCTS
      • INFLAMMATION AND IMMUNOLOGY
      • NEUROSCIENCE
      • VACCINES
      • OTHERS
      • MARKET REVENUE
        • TABLE 30: GLOBAL MARKET FOR CONTRACT MANUFACTURING AND RESEARCH OF DRUGS BY THERAPEUTIC AREA, THROUGH 2018 ($ MILLIONS)
        • FIGURE 15: GLOBAL MARKET FOR CONTRACT MANUFACTURING AND RESEARCH OF DRUGS BY THERAPEUTIC AREA, 2011-2018 ($ MILLIONS)
    • MARKET SHARES
      • TABLE 31: CONTRACT MANUFACTURING AND RESEARCH MARKET SHARES BY THERAPEUTIC AREA, 2012 (%)
      • FIGURE 16: CONTRACT MANUFACTURING AND RESEARCH MARKET SHARES BY THERAPEUTIC AREA, 2012 (%)

CHAPTER 7 - CONTRACT MANUFACTURING MARKET

  • CONTRACT MANUFACTURE OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 32: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS BY REGION, THROUGH 2018 ($ BILLIONS)
      • FIGURE 17: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS BY REGION, 2011-2018 ($ BILLIONS)
  • CONTRACT MANUFACTURE OF DOSAGE FORMS
    • MARKET BY TYPE
      • Market Overview
      • Market Revenue
        • TABLE 33: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS, THROUGH 2018 ($ BILLIONS)
        • FIGURE 18: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS, 2011-2018 ($ BILLIONS)
    • MARKET BY REGION
      • Solid Dosage Form
        • Market Overview
        • Market Revenue
          • TABLE 34: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY REGION, THROUGH 2018 ($ BILLIONS)
          • FIGURE 19: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY REGION, 2011-2018 ($ BILLIONS)
      • Liquid Dosage Forms
        • Market Overview
        • Market Revenue from Non-sterile Formulations
          • TABLE 35: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON-STERILE) BY REGION, THROUGH 2018 ($ MILLIONS)
          • FIGURE 20: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON STERILE) BY REGION, 2011-2018 ($ MILLIONS)
        • Market Revenues from Sterile Formulations
          • TABLE 36: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORM (STERILE) DRUGS BY REGION, THROUGH 2018 ($ MILLIONS)
          • FIGURE 21: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORM (STERILE) DRUGS BY REGION, 2011-2018 ($ MILLIONS)
      • Semisolid Dosage Forms
        • Market Overview
        • Market Revenue
          • TABLE 37: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY REGION, THROUGH 2018 ($ MILLIONS)
          • FIGURE 22: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY REGION, 2011-2018 ($ MILLIONS)
    • MARKET BY FORMULATION
      • Solid Dosage Forms
        • Market Revenue
          • TABLE 38: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY FORMULATION, THROUGH 2018 ($ BILLIONS)
          • FIGURE 23: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY FORMULATION, 2011-2018 ($ BILLIONS)
        • Market Share
          • TABLE 39: MARKET SHARES OF CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY FORMULATION, 2012 (%)
          • FIGURE 24: MARKET SHARES OF CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY FORMULATION, 2012 (%)
      • Liquid Dosage Forms
        • Market Revenue from Non-sterile Forms
          • TABLE 40: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON-STERILE) BY FORMULATION, THROUGH 2018 ($ MILLIONS)
          • FIGURE 25: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON-STERILE) BY FORMULATION, 2011-2018 ($ MILLIONS)
        • Market Share of Non-sterile Formulations
          • TABLE 41: MARKET SHARES OF CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON-STERILE) BY FORMULATION, 2012 (%)
          • FIGURE 26: MARKET SHARES OF CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON-STERILE) BY FORMULATION, 2012 (%)
        • Market for Sterile Formulations
          • TABLE 42: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (STERILE) BY FORMULATION, THROUGH 2018 ($ MILLIONS)
          • FIGURE 27: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (STERILE) BY FORMULATION, 2011-2018 ($ MILLIONS)
        • Market Shares of Sterile Formulations
          • TABLE 43: MARKET SHARES OF CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (STERILE) BY FORMULATION, 2012 (%)
          • FIGURE 28: MARKET SHARES OF CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (STERILE) BY FORMULATION, 2012 (%)
      • Semisolid Dosage Forms
        • Market Revenue
          • TABLE 44: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY FORMULATION, THROUGH 2018 ($ MILLIONS)
          • FIGURE 29: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY FORMULATION, 2011-2018 ($ MILLIONS)
        • Market Shares
          • TABLE 45: MARKET SHARES OF CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY FORMULATION, 2012 (%)
          • FIGURE 30: MARKET SHARES OF CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY FORMULATION, 2012 (%)
    • CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS
      • MARKET OVERVIEW
        • TABLE 46: EXAMPLES OF CONTRACTING COMPANIES PROVIDING DRUG-DELIVERY SYSTEMS
      • MARKET BY REGION
        • TABLE 47: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY REGION, THROUGH 2018 ($ BILLIONS)
        • FIGURE 31: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY REGION, 2011-2018 ($ BILLIONS)
      • MARKET BY FORMULATIONS
        • TABLE 48: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY TYPE, THROUGH 2018 ($ MILLIONS)
        • FIGURE 32: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY TYPE, 2011-2018 ($ MILLIONS)
      • MARKET SHARE
        • TABLE 49: MARKET SHARES OF CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY TYPE, 2012 (%)
        • FIGURE 33: MARKET SHARES OF CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY TYPE, 2012 (%)
    • CONTRACT MANUFACTURE OF OTC DRUGS AND NUTRITIONAL PRODUCTS
      • MARKET BY REGION
        • Market Revenue
          • TABLE 50: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY REGION, THROUGH 2018 ($ BILLIONS)
          • FIGURE 34: GLOBAL MARKET FOR CONTRACT MANUFACTURING OTC DRUGS AND NUTRITIONAL PRODUCTS BY REGION, 2011-2018 ($ BILLIONS)
      • MARKET BY FORMULATION TYPE
        • TABLE 51: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, THROUGH 2018 ($ BILLIONS)
        • FIGURE 35: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2011-2018 ($ BILLIONS)
      • Market Share
        • TABLE 52: MARKET SHARES OF CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2012 (%)
        • FIGURE 36: MARKET SHARE S OF CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2012 (%)
    • CONTRACT MANUFACTURING OF BULK DRUGS AND DOSAGE FORMS BY APPLICATION/THERAPEUTIC AREA
      • CARDIOVASCULAR
      • ANTIBIOTICS
      • ANALGESICS
      • ONCOLOGY
      • ANTIVIRALS
      • REPRODUCTIVE DRUG PRODUCTS
      • OTHER DRUGS
      • MARKET REVENUE
        • TABLE 53: GLOBAL MARKET FOR PHARMACEUTICAL CONTRACT MANUFACTURING BY THERAPEUTIC AREA, THROUGH 2018 ($ MILLIONS)
        • FIGURE 37: GLOBAL MARKET FOR PHARMACEUTICAL CONTRACT MANUFACTURING BY THERAPEUTIC AREA, 2011-2018 ($ MILLIONS)
      • MARKET SHARE
        • TABLE 54: MARKET SHARES OF VARIOUS THERAPEUTIC CATEGORIES OF CONTRACT MANUFACTURING, 2012 (%)
        • FIGURE 38: MARKET SHARES OF VARIOUS THERAPEUTIC CATEGORIES OF CONTRACT MANUFACTURING, 2012 (%)
    • INDUSTRY STRUCTURE
      • MARKET LEADERS
        • TABLE 55: SERVICES PROVIDED BY CONTRACT MANUFACTURING FIRMS
      • MARKET SHARES
        • Bulk Drugs and APIs
          • TABLE 56: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, 2012 (%)
          • FIGURE 39: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES
    • PROVIDING BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, 2012 (%)
      • Solid Dosage Forms
        • TABLE 57: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2012 (%)
        • FIGURE 40: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2012 (%)
      • Liquid Dosage Forms
        • Non-sterile
          • TABLE 58: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2012 (%)
          • FIGURE 41: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2012 (%)
        • Sterile
          • TABLE 59: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2012 (%)
          • FIGURE 42: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2012 (%)
      • Semisolid Dosage Forms
        • TABLE 60: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2012 (%)
        • FIGURE 43: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2012 (%)

CHAPTER 8 - CONTRACT RESEARCH MARKET

  • MARKET BY DISCIPLINE
    • MARKET OVERVIEW
      • MARKET REVENUE
        • TABLE 61: GLOBAL MARKET FOR CONTRACT RESEARCH BY DISCIPLINE, THROUGH 2018 ($ BILLIONS)
        • FIGURE 44: GLOBAL MARKET FOR CONTRACT RESEARCH BY DISCIPLINE, 2011-2018 ($ BILLIONS)
      • MARKET SHARES
        • TABLE 62: MARKET SHARES OF CONTRACT RESEARCH BY DISCIPLINE, 2012 (%)
        • FIGURE 45: MARKET SHARES OF CONTRACT RESEARCH BY DISCIPLINE, 2012 (%)
    • MARKET BY REGION
      • MARKET OVERVIEW
      • MARKET REVENUE
        • TABLE 63: GLOBAL MARKET FOR CONTRACT RESEARCH BY REGION, THROUGH 2018 ($ BILLIONS)
        • FIGURE 46: GLOBAL MARKET FOR CONTRACT RESEARCH BY REGION, 2011-2018 ($ BILLIONS)
      • MARKET SHARES
        • TABLE 64: CONTRACT RESEARCH MARKET SHARES BY REGION, 2012 (%)
        • FIGURE 47: CONTRACT RESEARCH MARKET SHARES BY REGION, 2012 (%)
      • Contract Clinical Research Market by Region
        • TABLE 65: GLOBAL MARKET FOR CONTRACT CLINICAL RESEARCH BY REGION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 48: GLOBAL MARKET FOR CONTRACT CLINICAL RESEARCH BY REGION, 2011-2018 ($ MILLIONS)
      • Contract Drug Discovery Market by Region
        • TABLE 66: GLOBAL MARKET FOR CONTRACT DRUG DISCOVERY BY REGION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 49: GLOBAL MARKET FOR CONTRACT DRUG DISCOVERY BY REGION, 2011-2018 ($ MILLIONS)
      • Contract Analytical Research Market by Region
        • TABLE 67: GLOBAL MARKET FOR CONTRACT ANALYTICAL RESEARCH BY REGION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 50: GLOBAL MARKET FOR CONTRACT ANALYTICAL RESEARCH BY REGION, 2011-2018 ($ MILLIONS)
      • Other Contract Research Activities Market by Region
        • TABLE 68: GLOBAL MARKET FOR OTHER CONTRACT RESEARCH SERVICES BY REGION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 51: GLOBAL MARKET FOR OTHER CONTRACT RESEARCH SERVICES BY REGION, 2011-2018 ($ MILLIONS)
    • MARKET BY THERAPEUTIC AREA
      • CARDIOLOGY
      • ONCOLOGY
      • INFLAMMATION AND IMMUNOLOGY
      • NEUROSCIENCE
      • VACCINES
      • OTHERS
      • MARKET REVENUE
        • TABLE 69: GLOBAL MARKET FOR CONTRACT RESEARCH BY THERAPEUTIC AREA, THROUGH 2018 ($ MILLIONS)
        • FIGURE 52: GLOBAL MARKET FOR CONTRACT RESEARCH BY THERAPEUTIC AREA, 2011-2018 ($ MILLIONS)
      • MARKET SHARE
        • TABLE 70: MARKET SHARES OF CONTRACT RESEARCH BY THERAPEUTIC AREA, 2012 (%)
        • FIGURE 53: MARKET SHARES OF CONTRACT RESEARCH BY THERAPEUTIC AREA, 2012 (%)
    • INDUSTRY STRUCTURE
      • MARKET LEADERS
        • TABLE 71: SERVICES PROVIDED BY RESEARCH FIRMS
      • MARKET SHARES
        • TABLE 72: MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2012 (%)
        • FIGURE 54: MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2012 (%)

CHAPTER 9 - CONTRACT PACKAGING MARKETS

  • MARKET BY TYPE
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 73: GLOBAL MARKET FOR CONTRACT PACKAGING BY TYPE, THROUGH 2018 ($ MILLIONS)
      • FIGURE 55: GLOBAL MARKET FOR CONTRACT PACKAGING BY TYPE, 2011-2018 ($ MILLIONS)
      • TABLE 74: GLOBAL MARKET FOR PRIMARY PACKAGING, THROUGH 2018 ($ MILLIONS)
      • FIGURE 56: GLOBAL MARKET FOR PRIMARY PACKAGING, 2011-2018 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 75: MARKET SHARES OF CONTRACT PACKAGING BY TYPE, 2012 (%)
      • FIGURE 57: MARKET SHARES OF CONTRACT PACKAGING BY TYPE, 2012 (%)
  • MARKET BY REGION
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 76: GLOBAL MARKET FOR CONTRACT PACKAGING BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 58: GLOBAL MARKET FOR CONTRACT PACKAGING BY REGION, 2011-2018 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 77: MARKET SHARES OF CONTRACT PACKAGING BY REGION, 2012 (%)
      • FIGURE 59: MARKET SHARES OF CONTRACT PACKAGING BY REGION, 2012 (%)
    • Primary Packaging by Region
      • TABLE 78: GLOBAL MARKET FOR PRIMARY PACKAGING BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 60: GLOBAL MARKET FOR PRIMARY PACKAGING BY REGION, 2011-2018 ($ MILLIONS)
    • Secondary Packaging by Region
      • TABLE 79: GLOBAL MARKET FOR SECONDARY PACKAGING BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 61: GLOBAL MARKET FOR SECONDARY PACKAGING BY REGION, 2011-2018 ($ MILLIONS)
    • Other Types of Packaging by Region
      • TABLE 80: GLOBAL MARKET FOR OTHER PACKAGING BY REGION, THROUGH 2018 ($ MILLIONS)
  • INDUSTRY STRUCTURE
    • MARKET LEADERS
      • TABLE 81: SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE, 2012
    • MARKET SHARE
      • TABLE 82: MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2012 (%)
      • FIGURE 63: MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2012 (%)

CHAPTER 10 - PATENT ANALYSIS

  • PATENTS BY YEAR
    • TABLE 83: SIGNIFICANT U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY YEAR, 2010-FEB. 2013 (NO.)
    • FIGURE 64: SIGNIFICANT U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY YEAR, 2010-FEB. 2013 (NO.)
  • PATENTS BY EMPHASIS
    • TABLE 84: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY EMPHASIS, 2010-FEB. 2013 (NO.)
    • FIGURE 65: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY EMPHASIS, 2010-FEB. 2013 (NO.)
  • PATENTS BY COMPANY
    • TABLE 85: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES, 2010-FEB. 2013 (NO.)
  • PATENTS BY THE PATENT HOLDER'S COUNTRY
    • TABLE 86: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY THE PATENT HOLDER'S COUNTRY, 2010-FEB. 2013 (NO.)
    • FIGURE 66: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY PATENT HOLDER'S COUNTRY, 2010-FEB. 2013 (NO.)
    • TABLE 87: SHARES OF U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY PATENT HOLDER'S COUNTRY, 2010-FEB. 2013 (%)
    • FIGURE 67: SHARES OF U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY PATENT HOLDER'S COUNTRY, 2010-FEB. 2013 (%)
  • PATENTS BY PATENT HOLDER TYPE
    • TABLE 88: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY TYPE OF PATENT HOLDER, 2010-FEB. 2013 (NO.)
    • FIGURE 68: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY TYPE OF PATENT HOLDER, 2010-FEB. 2013 (NO.)

CHAPTER 11 - CURRENT MARKET ENVIRONMENT

  • FACTORS AFFECTING THE OUTSOURCING MARKET
    • COST SAVINGS
    • STRINGENT REGULATIONS
    • PATENT EXPIRIES
    • DECREASING RESEARCH AND DEVELOPMENT SUCCESS RATES
    • INCREASING DEMAND FOR BIOSIMILARS
    • PHARMACEUTICAL OUTSOURCING TRENDS

CHAPTER 12 - COMPANY PROFILES

  • 3M CO.
  • AAI PHARMA INC.
  • ABBOTT LABORATORIES
  • AEROGEN LTD.
  • ALBANY MOLECULAR RESEARCH INC. (AMRI)
  • ALKERMES PLC
  • ALTHEA TECHNOLOGIES
  • AMCOR
  • AMERISOURCEBERGEN CORP.
  • AMPAC FINE CHEMICALS
  • A.P. PHARMA INC.
  • APTIV SOLUTIONS
  • APTUIT INC.
  • ARADIGM CORP.
  • BASF SE
  • BAXTER HEALTHCARE
  • BCM/BOOTS MANUFACTURING
  • BOEHRINGER INGELHEIM
  • CAMBREX CORP.
  • CANGENE BIOPHARMA INC.
  • CATALENT PHARMA SOLUTIONS
  • CEDARBURG HAUSER PHARMACEUTICALS INC.
  • CENEXI
  • CHARLES RIVER LABORATORIES
  • CHEMBRIDGE CORP.
  • CONFAB LABORATORIES
  • COVANCE INC.
  • COVIDIEN
  • CONTRACT PHARMACEUTICALS LTD.
  • CORDENPHARMA SWITZERLAND LLC
  • DECODE GENETICS
  • DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
  • DOW PHARMACEUTICAL SCIENCES
  • DPT LABORATORIES INC.
  • DR. REDDY'S LABORATORIES
  • DSM PHARMACEUTICAL PRODUCTS
  • FUJIFILM DIOSYNTH BIOTECHNOLOGY
  • ELAN DRUG TECHNOLOGIES
  • EVOTEC AG
  • GIRINDUS AG
  • GLAXOSMITHKLINE
  • GRIFOLS INTERNATIONAL SA
  • HOSPIRA
  • HAUPT PHARMA AG
  • HOVIONE SA
  • ICON PLC
  • INC RESEARCH LLC
  • JUBILANT LIFESCIENCES
  • KENDLE INTERNATIONAL INC.
  • KP PHARMACEUTICAL TECHNOLOGIES INC.
  • LIGAND PHARMACEUTICALS INC.
  • LONZA GROUP
  • LYNE LABORATORIES
  • MEADWESTVACO CORP.
  • MIKART INC.
  • NEXTPHARMA TECHNOLOGIES
  • NORWICH PHARMACEUTICALS
  • NOVAVAX INC.
  • PAREXEL INTERNATIONAL CORP.
  • PATHEON INC.
  • PERRIGO CO.
  • PFIZER CENTRESOURCE
  • PIRAMAL HEALTHCARE LTD.
  • PPD
  • PRA INTERNATIONAL
  • QUINTILES
  • RANBAXY LABORATORIES LTD.
  • RECIPHARM AB
  • REGIS TECHNOLOGIES INC.
  • SCHOTT PHARMACEUTICAL PACKAGING
  • SKYEPHARMA PLC
  • TAKEDA PHARMACEUTICALS
  • THEOREM CLINICAL RESEARCH
  • VETTER PHARMA INTERNATIONAL GMBH
  • WOCKHARDT LTD.
  • WUXI APP TEC
  • XCELLEREX LLC
  • ZACH SYSTEM SPA

CHAPTER 13 - APPENDIX: ACRONYMS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL CONTRACT MANUFACTURING, RESEARCH AND PACKAGING, THROUGH 2018 ($ BILLIONS)
    • TABLE 1: KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
    • TABLE 2: KEY ADVANTAGES OF CONTRACT MANUFACTURING
    • TABLE 3: KEY DISADVANTAGES OF CONTRACT MANUFACTURING
    • TABLE 4: KEY FACTORS IN SELECTING A CONTRACT MANUFACTURER
    • TABLE 5: SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATIONS
    • TABLE 6: KEY FACTORS IN SELECTING A CONTRACT RESEARCH ORGANIZATION
    • TABLE 7: TYPES OF SERVICES PROVIDED BY CONTRACT RESEARCH ORGANIZATIONS
    • TABLE 8: REASONS COMPANIES HIRE CONTRACT PACKAGERS
    • TABLE 9: WARNING LETTERS ISSUED TO PHARMACEUTICAL CONTRACT MANUFACTURERS, 2012
    • TABLE 10: WARNING LETTERS ISSUED TO PHARMACEUTICAL CONTRACT MANUFACTURERS, 2011
    • TABLE 11: WARNING LETTERS ISSUED TO PHARMACEUTICAL CONTRACT MANUFACTURERS, 2010
    • TABLE 12: REGULATORY APPROVALS OF PHARMACEUTICAL CONTRACT MANUFACTURER ACTIVITIES AND FACILITIES, JAN. AND FEB. 2013
    • TABLE 13: REGULATORY APPROVALS OF PHARMACEUTICAL CONTRACT MANUFACTURER ACTIVITIES AND FACILITIES, 2012
    • TABLE 14: REGULATORY APPROVALS OF PHARMACEUTICAL CONTRACT MANUFACTURER ACTIVITIES AND FACILITIES, 2011
    • TABLE 15: REGULATORY APPROVALS OF CONTRACT MANUFACTURER ACTIVITIES AND FACILITIES, 2010
    • TABLE 16: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS AND VARIOUS DOSAGE FORMS, THROUGH 2018 ($ BILLIONS)
    • TABLE 17: MARKET SHARES OF CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS AND VARIOUS DOSAGE FORMS, 2012 (%)
    • TABLE 18: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, THROUGH 2018 ($ BILLIONS)
    • TABLE 19: MARKET SHARES OF CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2012 (%)
    • TABLE 20: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, VARIOUS DOSAGE FORMS AND OTC DRUGS/NUTRITIONAL PRODUCTS, THROUGH 2018 ($ BILLIONS)
    • TABLE 21: MARKET SHARES OF CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, VARIOUS DOSAGE FORMS AND OTC DRUGS/NUTRITIONAL PRODUCTS, 2012 (%)
    • TABLE 22: GLOBAL MARKET FOR CONTRACT RESEARCH BY SEGMENT, THROUGH 2018 ($ BILLIONS)
    • TABLE 23: CONTRACT RESEARCH MARKET SHARES BY SEGMENT, 2012 (%)
    • TABLE 24: GLOBAL MARKET FOR CONTRACT PACKAGING BY TYPE, THROUGH 2018 ($ BILLIONS)
    • TABLE 25: MARKET SHARES OF CONTRACT PACKAGING BY TYPE, 2012 (%)
    • TABLE 26: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS AND BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS BY REGION, THROUGH 2018 ($ BILLIONS)
    • TABLE 27: REGIONAL MARKETS SHARES OF CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS AND BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, 2012 (%)
    • TABLE 28: GLOBAL MARKET FOR CONTRACT MANUFACTURING, RESEARCH AND PACKAGING BY REGION, THROUGH 2018 ($ BILLIONS)
    • TABLE 29: REGIONAL MARKET SHARES OF CONTRACT MANUFACTURING, RESEARCH AND PACKAGING, 2012 (%)
    • TABLE 30: GLOBAL MARKET FOR CONTRACT MANUFACTURING AND RESEARCH OF DRUGS BY THERAPEUTIC AREA, THROUGH 2018 ($ MILLIONS)
    • TABLE 31: CONTRACT MANUFACTURING AND RESEARCH MARKET SHARES BY THERAPEUTIC AREA, 2012 (%)
    • TABLE 32: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS BY REGION, THROUGH 2018 ($ BILLIONS)
    • TABLE 33: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS, THROUGH 2018 ($ BILLIONS)
    • TABLE 34: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY REGION, THROUGH 2018 ($ BILLIONS)
    • TABLE 35: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON-STERILE) BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 36: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORM (STERILE) DRUGS BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 38: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY FORMULATION, THROUGH 2018 ($ BILLIONS)
    • TABLE 39: MARKET SHARES OF CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY FORMULATION, 2012 (%)
    • TABLE 40: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON-STERILE) BY FORMULATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 41: MARKET SHARES OF CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON-STERILE) BY FORMULATION, 2012 (%)
    • TABLE 42: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (STERILE) BY FORMULATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 43: MARKET SHARES OF CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (STERILE) BY FORMULATION, 2012 (%)
    • TABLE 44: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY FORMULATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 45: MARKET SHARES OF CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY FORMULATION, 2012 (%)
    • TABLE 46: EXAMPLES OF CONTRACTING COMPANIES PROVIDING DRUG-DELIVERY SYSTEMS
    • TABLE 47: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY REGION, THROUGH 2018 ($ BILLIONS)
    • TABLE 48: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY TYPE, THROUGH 2018 ($ MILLIONS)
    • TABLE 49: MARKET SHARES OF CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY TYPE, 2012 (%)
    • TABLE 50: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY REGION, THROUGH 2018 ($ BILLIONS)
    • TABLE 51: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, THROUGH 2018 ($ BILLIONS)
    • TABLE 52: MARKET SHARES OF CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2012 (%)
    • TABLE 53: GLOBAL MARKET FOR PHARMACEUTICAL CONTRACT MANUFACTURING BY THERAPEUTIC AREA, THROUGH 2018 ($ MILLIONS)
    • TABLE 54: MARKET SHARES OF VARIOUS THERAPEUTIC CATEGORIES OF CONTRACT MANUFACTURING, 2012 (%)
    • TABLE 55: SERVICES PROVIDED BY CONTRACT MANUFACTURING FIRMS
    • TABLE 56: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, 2012 (%)
    • TABLE 57: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2012 (%)
    • TABLE 58: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2012 (%)
    • TABLE 59: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2012 (%)
    • TABLE 60: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2012 (%)
    • TABLE 61: GLOBAL MARKET FOR CONTRACT RESEARCH BY DISCIPLINE, THROUGH 2018 ($ BILLIONS)
    • TABLE 62: MARKET SHARES OF CONTRACT RESEARCH BY DISCIPLINE, 2012 (%)
    • TABLE 63: GLOBAL MARKET FOR CONTRACT RESEARCH BY REGION, THROUGH 2018 ($ BILLIONS)
    • TABLE 64: CONTRACT RESEARCH MARKET SHARES BY REGION, 2012 (%)
    • TABLE 65: GLOBAL MARKET FOR CONTRACT CLINICAL RESEARCH BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 66: GLOBAL MARKET FOR CONTRACT DRUG DISCOVERY BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 67: GLOBAL MARKET FOR CONTRACT ANALYTICAL RESEARCH BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 68: GLOBAL MARKET FOR OTHER CONTRACT RESEARCH SERVICES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 69: GLOBAL MARKET FOR CONTRACT RESEARCH BY THERAPEUTIC AREA, THROUGH 2018 ($ MILLIONS)
    • TABLE 70: MARKET SHARES OF CONTRACT RESEARCH BY THERAPEUTIC AREA, 2012 (%)
    • TABLE 71: SERVICES PROVIDED BY RESEARCH FIRMS
    • TABLE 72: MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2012 (%)
    • TABLE 73: GLOBAL MARKET FOR CONTRACT PACKAGING BY TYPE, THROUGH 2018 ($ MILLIONS)
    • TABLE 74: GLOBAL MARKET FOR PRIMARY PACKAGING, THROUGH 2018 ($ MILLIONS)
    • TABLE 75: MARKET SHARES OF CONTRACT PACKAGING BY TYPE, 2012 (%)
    • TABLE 76: GLOBAL MARKET FOR CONTRACT PACKAGING BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 77: MARKET SHARES OF CONTRACT PACKAGING BY REGION, 2012 (%)
    • TABLE 78: GLOBAL MARKET FOR PRIMARY PACKAGING BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 79: GLOBAL MARKET FOR SECONDARY PACKAGING BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 80: GLOBAL MARKET FOR OTHER PACKAGING BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 81: SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE, 2012
    • TABLE 82: MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2012 (%)
    • TABLE 83: SIGNIFICANT U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY YEAR, 2010-FEB. 2013 (NO.)
    • TABLE 84: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY EMPHASIS, 2010-FEB. 2013 (NO.)
    • TABLE 85: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES, 2010-FEB. 2013 (NO.)
    • TABLE 86: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY THE PATENT HOLDER'S COUNTRY, 2010-FEB. 2013 (NO.)
    • TABLE 87: SHARES OF U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY PATENT HOLDER'S COUNTRY, 2010-FEB. 2013 (%)
    • TABLE 88: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY TYPE OF PATENT HOLDER, 2010-FEB. 2013 (NO.)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL CONTRACT MANUFACTURING, RESEARCH AND PACKAGING, 2011-2018 ($ BILLIONS)
    • FIGURE 1: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS AND VARIOUS DOSAGE FORMS, 2011-2018 ($ BILLIONS)
    • FIGURE 2: MARKET SHARES OF CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS AND VARIOUS DOSAGE FORMS, 2012 (%)
    • FIGURE 3: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2011-2018 ($ BILLIONS)
    • FIGURE 4: MARKET SHARES OF CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2012 (%)
    • FIGURE 5: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, VARIOUS DOSAGE FORMS AND OTC DRUGS/NUTRITIONAL PRODUCTS, 2011-2018 ($ BILLIONS)
    • FIGURE 6: MARKET SHARES OF CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, VARIOUS DOSAGE FORMS AND OTC DRUGS/NUTRITIONAL PRODUCTS, 2012 (%)
    • FIGURE 7: GLOBAL MARKET FOR CONTRACT RESEARCH BY SEGMENT, 2011-2018 ($ BILLIONS)
    • FIGURE 8: CONTRACT RESEARCH MARKET SHARES BY SEGMENT, 2012 (%)
    • FIGURE 9: GLOBAL MARKET FOR CONTRACT PACKAGING BY TYPE, 2011-2018 ($ BILLIONS)
    • FIGURE 10: MARKET SHARES OF CONTRACT PACKAGING BY TYPE, 2012 (%)
    • FIGURE 11: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS AND BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS BY REGION, 2011-2018 ($ BILLIONS)
    • FIGURE 12: REGIONAL MARKETS SHARES OF CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS AND BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, 2012 (%)
    • FIGURE 13: GLOBAL MARKET FOR CONTRACT MANUFACTURING, RESEARCH AND PACKAGING BY REGION, 2011-2018 ($ BILLIONS)
    • FIGURE 14: REGIONAL MARKET SHARES OF CONTRACT MANUFACTURING, RESEARCH AND PACKAGING, 2012 (%)
    • FIGURE 15: GLOBAL MARKET FOR CONTRACT MANUFACTURING AND RESEARCH OF DRUGS BY THERAPEUTIC AREA, 2011-2018 ($ MILLIONS)
    • FIGURE 16: CONTRACT MANUFACTURING AND RESEARCH MARKET SHARES BY THERAPEUTIC AREA, 2012 (%)
    • FIGURE 17: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS BY REGION, 2011-2018 ($ BILLIONS)
    • FIGURE 18: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS, 2011-2018 ($ BILLIONS)
    • FIGURE 19: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY REGION, 2011-2018 ($ BILLIONS)
    • FIGURE 20: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON STERILE) BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 21: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORM (STERILE) DRUGS BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 22: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 23: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY FORMULATION, 2011-2018 ($ BILLIONS)
    • FIGURE 24: MARKET SHARES OF CONTRACT MANUFACTURING OF SOLID DOSAGE FORMS BY FORMULATION, 2012 (%)
    • FIGURE 25: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON-STERILE) BY FORMULATION, 2011-2018 ($ MILLIONS)
    • FIGURE 26: MARKET SHARES OF CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (NON-STERILE) BY FORMULATION, 2012 (%)
    • FIGURE 27: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (STERILE) BY FORMULATION, 2011-2018 ($ MILLIONS)
    • FIGURE 28: MARKET SHARES OF CONTRACT MANUFACTURING OF LIQUID DOSAGE FORMS (STERILE) BY FORMULATION, 2012 (%)
    • FIGURE 29: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY FORMULATION, 2011-2018 ($ MILLIONS)
    • FIGURE 30: MARKET SHARES OF CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS BY FORMULATION, 2012 (%)
    • FIGURE 31: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY REGION, 2011-2018 ($ BILLIONS)
    • FIGURE 32: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY TYPE, 2011-2018 ($ MILLIONS)
    • FIGURE 33: MARKET SHARES OF CONTRACT MANUFACTURING OF ADVANCED DRUG DELIVERY SYSTEMS BY TYPE, 2012 (%)
    • FIGURE 34: GLOBAL MARKET FOR CONTRACT MANUFACTURING OTC DRUGS AND NUTRITIONAL PRODUCTS BY REGION, 2011-2018 ($ BILLIONS)
    • FIGURE 35: GLOBAL MARKET FOR CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2011-2018 ($ BILLIONS)
    • FIGURE 36: MARKET SHARE S OF CONTRACT MANUFACTURING OF OTC DRUGS AND NUTRITIONAL PRODUCTS BY FORMULATION, 2012 (%)
    • FIGURE 37: GLOBAL MARKET FOR PHARMACEUTICAL CONTRACT MANUFACTURING BY THERAPEUTIC AREA, 2011-2018 ($ MILLIONS)
    • FIGURE 38:: MARKET SHARES OF VARIOUS THERAPEUTIC CATEGORIES OF CONTRACT MANUFACTURING, 2012 (%)
    • FIGURE 39: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/ACTIVE PHARMACEUTICAL INGREDIENTS, 2012 (%)
    • FIGURE 40: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2012 (%)
    • FIGURE 41: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2012 (%)
    • FIGURE 42: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2012 (%)
    • FIGURE 43: MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2012 (%)
    • FIGURE 44: GLOBAL MARKET FOR CONTRACT RESEARCH BY DISCIPLINE, 2011-2018 ($ BILLIONS)
    • FIGURE 45: MARKET SHARES OF CONTRACT RESEARCH BY DISCIPLINE, 2012 (%)
    • FIGURE 46: GLOBAL MARKET FOR CONTRACT RESEARCH BY REGION, 2011-2018 ($ BILLIONS)
    • FIGURE 47: CONTRACT RESEARCH MARKET SHARES BY REGION, 2012 (%)
    • FIGURE 48: GLOBAL MARKET FOR CONTRACT CLINICAL RESEARCH BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 49: GLOBAL MARKET FOR CONTRACT DRUG DISCOVERY BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 50: GLOBAL MARKET FOR CONTRACT ANALYTICAL RESEARCH BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 51: GLOBAL MARKET FOR OTHER CONTRACT RESEARCH SERVICES BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 52: GLOBAL MARKET FOR CONTRACT RESEARCH BY THERAPEUTIC AREA, 2011-2018 ($ MILLIONS)
    • FIGURE 53: MARKET SHARES OF CONTRACT RESEARCH BY THERAPEUTIC AREA, 2012 (%)
    • FIGURE 54: MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2012 (%)
    • FIGURE 55: GLOBAL MARKET FOR CONTRACT PACKAGING BY TYPE, 2011-2018 ($ MILLIONS)
    • FIGURE 56: GLOBAL MARKET FOR PRIMARY PACKAGING, 2011-2018 ($ MILLIONS)
    • FIGURE 57: MARKET SHARES OF CONTRACT PACKAGING BY TYPE, 2012 (%)
    • FIGURE 58: GLOBAL MARKET FOR CONTRACT PACKAGING BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 59: MARKET SHARES OF CONTRACT PACKAGING BY REGION, 2012 (%)
    • FIGURE 60: GLOBAL MARKET FOR PRIMARY PACKAGING BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 61: GLOBAL MARKET FOR SECONDARY PACKAGING BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 63: MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2012 (%)
    • FIGURE 64: SIGNIFICANT U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY YEAR, 2010-FEB. 2013 (NO.)
    • FIGURE 65: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY EMPHASIS, 2010-FEB. 2013 (NO.)
    • FIGURE 66: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY PATENT HOLDER'S COUNTRY, 2010-FEB. 2013 (NO.)
    • FIGURE 67: SHARES OF U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY PATENT HOLDER'S COUNTRY, 2010-FEB. 2013 (%)
    • FIGURE 68: U.S. PATENTS GRANTED TO CONTRACT MANUFACTURING, RESEARCH AND PACKAGING COMPANIES BY TYPE OF PATENT HOLDER, 2010-FEB. 2013 (NO.)
Back to Top